• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎、急性心肌损伤与梗死。

COVID-19, Acute Myocardial Injury, and Infarction.

机构信息

Division of Cardiology, Santa Maria Goretti Hospital, Via Guido Reni 1, 04100 Latina, Italy; Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, United Kingdom.

出版信息

Card Electrophysiol Clin. 2022 Mar;14(1):29-39. doi: 10.1016/j.ccep.2021.10.004. Epub 2021 Oct 30.

DOI:10.1016/j.ccep.2021.10.004
PMID:35221083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8556597/
Abstract

Severe acute respiratory syndrome coronavirus-2 can affect the cardiovascular system yielding a wide range of complications, including acute myocardial injury. The myocardium can be damaged by direct viral invasion or indirect mechanisms, sustained by systemic inflammation, immune-mediated response, and dysregulation of the renin-angiotensin system. Myocardial injury affects about one-quarter of patients with COVID-19, can manifest even in the absence of previous cardiovascular disease, and is associated to higher mortality rates and long-term sequelae. This review describes the pathophysiological mechanisms of myocardial injury and infarction and discusses the main clinical outcomes and diagnostic challenges associated with myocardial damage during COVID-19.

摘要

严重急性呼吸综合征冠状病毒 2 可影响心血管系统,产生多种并发症,包括急性心肌损伤。心肌可能通过直接病毒侵袭或间接机制(由全身炎症、免疫介导反应和肾素-血管紧张素系统失调引起)受到损伤。心肌损伤影响约四分之一的 COVID-19 患者,即使在没有先前心血管疾病的情况下也可能发生,并且与更高的死亡率和长期后遗症相关。这篇综述描述了心肌损伤和梗死的病理生理学机制,并讨论了与 COVID-19 期间心肌损伤相关的主要临床结果和诊断挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0978/8556597/462b70cbfd3e/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0978/8556597/5aeac0da321d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0978/8556597/462b70cbfd3e/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0978/8556597/5aeac0da321d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0978/8556597/462b70cbfd3e/gr2_lrg.jpg

相似文献

1
COVID-19, Acute Myocardial Injury, and Infarction.新型冠状病毒肺炎、急性心肌损伤与梗死。
Card Electrophysiol Clin. 2022 Mar;14(1):29-39. doi: 10.1016/j.ccep.2021.10.004. Epub 2021 Oct 30.
2
Cardiovascular aspects of COVID-19.COVID-19 的心血管方面。
Swiss Med Wkly. 2020 Dec 31;150:w20417. doi: 10.4414/smw.2020.20417. eCollection 2020 Dec 14.
3
Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.了解肾素-血管紧张素-醛固酮-SARS-CoV 轴:全面综述。
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.00912-2020. Print 2020 Jul.
4
Direct mechanisms of SARS-CoV-2-induced cardiomyocyte damage: an update.SARS-CoV-2 诱导心肌细胞损伤的直接机制:最新进展。
Virol J. 2022 Jun 25;19(1):108. doi: 10.1186/s12985-022-01833-y.
5
[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].[新型冠状病毒肺炎(COVID-19)中的心肌损伤:心脏生物标志物的主要病理生理机制及临床应用]
Ann Biol Clin (Paris). 2021 Jun 1;79(3):219-231. doi: 10.1684/abc.2021.1642.
6
COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?COVID-19 大流行与肌钙蛋白:间接性心肌损伤、心肌炎症还是心肌炎?
Heart. 2020 Aug;106(15):1127-1131. doi: 10.1136/heartjnl-2020-317186. Epub 2020 Jun 4.
7
Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar.冠状病毒与心血管疾病、心肌损伤和心律失常:美国心脏病学会焦点研讨会。
J Am Coll Cardiol. 2020 Oct 27;76(17):2011-2023. doi: 10.1016/j.jacc.2020.08.059.
8
The potential role of SARS-CoV-2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread.严重急性呼吸综合征冠状病毒 2 感染在急性冠状动脉综合征和 2 型心肌梗死(T2MI)中的潜在作用:交织传播。
Immun Inflamm Dis. 2023 Mar;11(3):e798. doi: 10.1002/iid3.798.
9
[Cardiovascular diseases and COVID-19 : Pathophysiology, complications and treatment].[心血管疾病与2019冠状病毒病:病理生理学、并发症及治疗]
Herz. 2021 Mar;46(2):107-114. doi: 10.1007/s00059-020-05013-y. Epub 2021 Jan 4.
10
Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.新型冠状病毒相关肺损伤中经典肾素-血管紧张素系统与其拮抗系统之间的失衡。
Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L325-L336. doi: 10.1152/ajplung.00189.2020. Epub 2020 Jul 8.

引用本文的文献

1
Post-COVID-19 cardiovascular disease risk in kidney transplant recipients.肾移植受者中新冠病毒感染康复后的心血管疾病风险
Am J Transplant. 2025 Jul 15. doi: 10.1016/j.ajt.2025.07.2462.
2
Two-year follow-up of patients with myocardial injury during acute COVID-19: insights from the CARDIO COVID 20-21 registry.急性新冠肺炎期间心肌损伤患者的两年随访:来自CARDIO COVID 20 - 21注册研究的见解
Front Cardiovasc Med. 2025 Jun 11;12:1584732. doi: 10.3389/fcvm.2025.1584732. eCollection 2025.
3
Predictors of Mortality in Acute Myocardial Infarction: Insights From the Healthcare Cost and Utilization Project (HCUP) Nationwide Readmission Database.

本文引用的文献

1
Renin-Angiotensin-Aldosterone System and Immunomodulation: A State-of-the-Art Review.肾素-血管紧张素-醛固酮系统与免疫调节:最新综述。
Cells. 2021 Jul 13;10(7):1767. doi: 10.3390/cells10071767.
2
Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.瑞典 COVID-19 后急性心肌梗死和缺血性卒中的风险:一项自身对照病例系列和匹配队列研究。
Lancet. 2021 Aug 14;398(10300):599-607. doi: 10.1016/S0140-6736(21)00896-5. Epub 2021 Jul 29.
3
Cardiac complications during the active phase of COVID-19: review of the current evidence.
急性心肌梗死死亡率的预测因素:来自医疗保健成本与利用项目(HCUP)全国再入院数据库的见解
Cureus. 2025 May 7;17(5):e83675. doi: 10.7759/cureus.83675. eCollection 2025 May.
4
COVID-19 and Diabetes: Persistent Cardiovascular and Renal Risks in the Post-Pandemic Landscape.新冠疫情与糖尿病:大流行后持续存在的心血管和肾脏风险
Life (Basel). 2025 Apr 30;15(5):726. doi: 10.3390/life15050726.
5
Novel Insights into CKMB, Myoglobin, and Troponin I Levels as Predictors of COVID-19 Severity and Hospitalization Outcomes.对肌酸激酶同工酶(CKMB)、肌红蛋白和肌钙蛋白I水平作为COVID-19严重程度和住院结局预测指标的新见解。
Biomedicines. 2025 Mar 10;13(3):672. doi: 10.3390/biomedicines13030672.
6
Pandemics extend beyond infectious diseases: the emerging threat of non-communicable diseases.大流行并不局限于传染病:非传染性疾病正在成为新的威胁。
Korean J Intern Med. 2025 Mar;40(2):168-169. doi: 10.3904/kjim.2025.046. Epub 2025 Mar 1.
7
Classifying COVID-19 hospitalizations in epidemiology cohort studies: The C4R study.在流行病学队列研究中对新冠病毒疾病住院病例进行分类:C4R研究
PLoS One. 2025 Feb 10;20(2):e0316198. doi: 10.1371/journal.pone.0316198. eCollection 2025.
8
An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management Strategies.深入洞察新冠病毒相关心血管疾病的临床、细胞和分子因素,以确定新型疾病生物标志物、药物靶点和临床管理策略。
Arch Microbiol Immunol. 2024;8(3):290-308. doi: 10.26502/ami.936500177. Epub 2024 Jul 19.
9
COVID-19 Increases the Risk of New Myocardial Infarction in Patients with Old Myocardial Infarction: A Retrospective Observational Study.新冠病毒增加陈旧性心肌梗死患者新发心肌梗死风险:一项回顾性观察研究
Clin Med Insights Cardiol. 2024 Dec 18;18:11795468241301133. doi: 10.1177/11795468241301133. eCollection 2024.
10
Arterial Thrombosis in Acute Respiratory Infections: An Underestimated but Clinically Relevant Problem.急性呼吸道感染中的动脉血栓形成:一个被低估但具有临床相关性的问题。
J Clin Med. 2024 Oct 9;13(19):6007. doi: 10.3390/jcm13196007.
COVID-19 活动期的心脏并发症:当前证据综述。
Intern Emerg Med. 2021 Nov;16(8):2051-2061. doi: 10.1007/s11739-021-02763-3. Epub 2021 May 27.
4
What we (don't) know about myocardial injury after COVID-19.关于新冠病毒病后心肌损伤我们(不)了解的情况。
Eur Heart J. 2021 May 14;42(19):1879-1882. doi: 10.1093/eurheartj/ehab145.
5
Impact of National Lockdown on the Hyperacute Stroke Care and Rapid Transient Ischaemic Attack Outpatient Service in a Comprehensive Tertiary Stroke Centre During the COVID-19 Pandemic.新冠疫情期间全国封锁对一家综合性三级卒中中心超急性卒中护理及短暂性脑缺血发作快速门诊服务的影响
Front Neurol. 2021 Feb 11;12:627493. doi: 10.3389/fneur.2021.627493. eCollection 2021.
6
Cardiac Injury in COVID-19: A Systematic Review.新型冠状病毒肺炎相关心肌损伤:系统评价。
Adv Exp Med Biol. 2021;1321:325-333. doi: 10.1007/978-3-030-59261-5_29.
7
Evaluation of myocardial injury patterns and ST changes among critical and non-critical patients with coronavirus-19 disease.评价危重症和非危重症新型冠状病毒 19 型疾病患者的心肌损伤模式和 ST 变化。
Sci Rep. 2021 Mar 1;11(1):4828. doi: 10.1038/s41598-021-84467-4.
8
Myocardial injury in hospitalized patients with COVID-19 infection-Risk factors and outcomes.COVID-19 感染住院患者的心肌损伤-危险因素和结局。
PLoS One. 2021 Feb 26;16(2):e0247800. doi: 10.1371/journal.pone.0247800. eCollection 2021.
9
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance.心血管磁共振评估恢复性肌钙蛋白阳性 COVID-19 患者的心肌损伤模式。
Eur Heart J. 2021 May 14;42(19):1866-1878. doi: 10.1093/eurheartj/ehab075.
10
COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications.2019冠状病毒病与急性冠状动脉综合征:当前数据及未来影响
Front Cardiovasc Med. 2021 Jan 28;7:593496. doi: 10.3389/fcvm.2020.593496. eCollection 2020.